3D Dynamic Imaging of Soft Materials Using Transmission Electron Microscopy
|
By LabMedica International staff writers Posted on 17 Oct 2013 |

Image: Schematic of a graphene liquid cell shows multiple liquid pockets containing single nanoparticles, dimers composed of dsDNA bridges in different lengths, and trimers (Photo courtesy of DOE/Lawrence Berkeley National Laboratory).
Through a combination of transmission electron microscopy (TEM) and their own distinct graphene liquid cell, researchers have recorded the three-dimensional (3D) motion of DNA connected to gold nanocrystals. This is the first time TEM has been used for 3D dynamic imaging of so-called “soft materials.”
A new movie has been produced by researchers at the US Department of Energy (DOE)’s Lawrence Berkeley National Laboratory (Berkeley Lab; Berkeley, CA, USA). “Our demonstration of 3D dynamic imaging goes beyond TEM’s conventional use in seeing flat, dry samples and opens many exciting opportunities for studying the dynamics of biological macromolecular assemblies and artificial nanostructures,” said physicist Dr. Alex Zettl, one of the leaders of this research. “These results were made possible by our novel graphene liquid cell, which can meet the challenges of using TEM to image soft materials.”
Dr. Zettl, who holds joint appointments with Berkeley Lab’s materials sciences division and the University of California (UC) Berkeley’s physics department where he directs the Center of Integrated Nanomechanical Systems, is one of the coauthors of an article published online August 14, 2013, in the journal NANO Letters describing this research.
The term soft materials refers a wide range of substances, including proteins, DNA, and other biologic compounds, plastics, therapeutic drugs, flexible electronics, and certain types of photovoltaics. In spite of their universal presence, soft materials pose many problems because the study of their dynamics at the nanoscale; in particular, biologic systems, has been a challenge. TEM, in which a beam of electrons rather than light is used for illumination and magnification, provides the resolution for such research but can only be used in a high vacuum as molecules in the air disrupt the electron beam. Because liquids evaporate in high vacuum, samples of soft materials, which have been described as “highly viscous fluids,” must be hermetically sealed in special solid containers (called cells) with a viewing window before being imaged with TEM.
In the past, liquid cells featured silicon-based viewing windows whose thickness limited resolution and agitated the natural state of the soft materials. Berkeley Lab’s Dr. Zettl and Dr. Paul Alivisatos, Berkeley Lab director, a coauthor of the study, and their coworkers overcame these hurdles with the development of a liquid cell based on a graphene membrane only a single atom thick. This project was conducted in close cooperation with researchers at the National Center for Electron Microscopy (NCEM), which is located at Berkeley Lab.
“Our graphene liquid cells pushed the spatial resolution of liquid phase TEM imaging to the atomic scale but still focused on growth trajectories of metallic nanocrystals,” said lead author Dr. Qian Chen, a postdoctoral fellow in Dr. Alivisatos’s research group. “Now we’ve adopted the technique to imaging the 3D dynamics of soft materials, starting with double-strand [dsDNA] connected to gold nanocrystals and achieved nanometer resolution.”
To design the cell, two opposing graphene sheets are bonded to one another by their van der Waals attraction. This forms a sealed nanoscale chamber and creates within the chamber a stable aqueous solution pocket approximately 100 nm in height and 1 µm in diameter. The single atom thick graphene membrane of the cells is essentially transparent to the TEM electron beam, minimizing the unwanted loss of imaging electrons and providing superior contrast and resolution compared to silicon-based windows. The aqueous pockets allow for up to two minutes of continuous imaging of soft material samples exposed to a 200 kV imaging electron beam. During this process, soft material samples can freely rotate.
After demonstrating that their graphene liquid cell can seal an aqueous sample solution against a TEM high vacuum, the Berkeley researchers used it to examine the types of gold-dsDNA nanoconjugates that have been widely used as dynamic plasmonic probes. “The presence of double-stranded DNA molecules incorporates the major challenges of studying the dynamics of biological samples with liquid phase TEM,” stated Dr. Alivisatos. “The high-contrast gold nanocrystals facilitate tracking of our specimens.”
The investigators were able to visualize dimers, pairs of gold nanoparticles, fastened by a single piece of dsDNA, and trimers, three gold nanoparticles, connected into a linear configuration by two single pieces of dsDNA. Over time, from a series of 2D projected TEM images captured while the samples were rotating, the researchers were to reconstruct 3D configuration and motions of the samples as they evolved. “This information would be inaccessible with conventional TEM techniques,” Dr. Chen remarked.
Related Links:
Lawrence Berkeley National Laboratory
A new movie has been produced by researchers at the US Department of Energy (DOE)’s Lawrence Berkeley National Laboratory (Berkeley Lab; Berkeley, CA, USA). “Our demonstration of 3D dynamic imaging goes beyond TEM’s conventional use in seeing flat, dry samples and opens many exciting opportunities for studying the dynamics of biological macromolecular assemblies and artificial nanostructures,” said physicist Dr. Alex Zettl, one of the leaders of this research. “These results were made possible by our novel graphene liquid cell, which can meet the challenges of using TEM to image soft materials.”
Dr. Zettl, who holds joint appointments with Berkeley Lab’s materials sciences division and the University of California (UC) Berkeley’s physics department where he directs the Center of Integrated Nanomechanical Systems, is one of the coauthors of an article published online August 14, 2013, in the journal NANO Letters describing this research.
The term soft materials refers a wide range of substances, including proteins, DNA, and other biologic compounds, plastics, therapeutic drugs, flexible electronics, and certain types of photovoltaics. In spite of their universal presence, soft materials pose many problems because the study of their dynamics at the nanoscale; in particular, biologic systems, has been a challenge. TEM, in which a beam of electrons rather than light is used for illumination and magnification, provides the resolution for such research but can only be used in a high vacuum as molecules in the air disrupt the electron beam. Because liquids evaporate in high vacuum, samples of soft materials, which have been described as “highly viscous fluids,” must be hermetically sealed in special solid containers (called cells) with a viewing window before being imaged with TEM.
In the past, liquid cells featured silicon-based viewing windows whose thickness limited resolution and agitated the natural state of the soft materials. Berkeley Lab’s Dr. Zettl and Dr. Paul Alivisatos, Berkeley Lab director, a coauthor of the study, and their coworkers overcame these hurdles with the development of a liquid cell based on a graphene membrane only a single atom thick. This project was conducted in close cooperation with researchers at the National Center for Electron Microscopy (NCEM), which is located at Berkeley Lab.
“Our graphene liquid cells pushed the spatial resolution of liquid phase TEM imaging to the atomic scale but still focused on growth trajectories of metallic nanocrystals,” said lead author Dr. Qian Chen, a postdoctoral fellow in Dr. Alivisatos’s research group. “Now we’ve adopted the technique to imaging the 3D dynamics of soft materials, starting with double-strand [dsDNA] connected to gold nanocrystals and achieved nanometer resolution.”
To design the cell, two opposing graphene sheets are bonded to one another by their van der Waals attraction. This forms a sealed nanoscale chamber and creates within the chamber a stable aqueous solution pocket approximately 100 nm in height and 1 µm in diameter. The single atom thick graphene membrane of the cells is essentially transparent to the TEM electron beam, minimizing the unwanted loss of imaging electrons and providing superior contrast and resolution compared to silicon-based windows. The aqueous pockets allow for up to two minutes of continuous imaging of soft material samples exposed to a 200 kV imaging electron beam. During this process, soft material samples can freely rotate.
After demonstrating that their graphene liquid cell can seal an aqueous sample solution against a TEM high vacuum, the Berkeley researchers used it to examine the types of gold-dsDNA nanoconjugates that have been widely used as dynamic plasmonic probes. “The presence of double-stranded DNA molecules incorporates the major challenges of studying the dynamics of biological samples with liquid phase TEM,” stated Dr. Alivisatos. “The high-contrast gold nanocrystals facilitate tracking of our specimens.”
The investigators were able to visualize dimers, pairs of gold nanoparticles, fastened by a single piece of dsDNA, and trimers, three gold nanoparticles, connected into a linear configuration by two single pieces of dsDNA. Over time, from a series of 2D projected TEM images captured while the samples were rotating, the researchers were to reconstruct 3D configuration and motions of the samples as they evolved. “This information would be inaccessible with conventional TEM techniques,” Dr. Chen remarked.
Related Links:
Lawrence Berkeley National Laboratory
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more







